(Q33406648)

26 July 2017

title

Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes (English)

1 reference

World Health Organization

26 July 2017

main subject

0 references

0 references

1 reference

chronic myelomonocytic leukemia

1 reference

14

A Tefferi

1 reference

26 July 2017

M M Patnaik

1

1 reference

26 July 2017

E Padron

2

1 reference

26 July 2017

R R LaBorde

3

1 reference

26 July 2017

T L Lasho

4

1 reference

26 July 2017

C M Finke

5

1 reference

26 July 2017

C A Hanson

6

1 reference

26 July 2017

J M Hodnefield

7

1 reference

26 July 2017

R A Knudson

8

1 reference

26 July 2017

R P Ketterling

9

1 reference

26 July 2017

A Al-kali

10

1 reference

26 July 2017

A Pardanani

11

1 reference

26 July 2017

N A Ali

12

1 reference

26 July 2017

R S Komrokji

13

1 reference

26 July 2017

publication date

27 March 2013

1 reference

26 July 2017

1 reference

26 July 2017

volume

27

1 reference

26 July 2017

issue

7

1 reference

26 July 2017

page(s)

1504-1510

1 reference

https://scigraph.springernature.com/pub.10.1038/leu.2013.88

26 July 2017

exact match

0 references

cites work

Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic leukemia: prevalence, clinical correlates, and prognostic relevance.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.88

Risk assessment in chronic myelomonocytic leukemia (CMML).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.88

Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.88

Cytogenetic risk stratification in chronic myelomonocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.88

Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.88

The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.88

The most commonly reported variant in ASXL1 (c.1934dupG;p.Gly646TrpfsX12) is not a somatic alteration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.88

Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.88

Frequent pathway mutations of splicing machinery in myelodysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.88

Mutations of ASXL1 gene in myeloproliferative neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.88

Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.88

SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.88

Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.88

Revised international prognostic scoring system for myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.88

Absolute monocyte/lymphocyte count prognostic score is independent of immunohistochemically determined cell of origin in predicting survival in diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.88

Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.88

Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.88

Myelodysplastic syndromes: a scoring system with prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.88

7 January 2021

New prognostic parameters for chronic myelomonocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.88

7 January 2021

Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.88

7 January 2021

Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.88

7 January 2021

SRSF2 mutations in primary myelofibrosis: significant clustering with IDH mutations and independent association with inferior overall and leukemia-free survival

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.88

7 January 2021

Monosomal karyotype in myelodysplastic syndromes, with or without monosomy 7 or 5, is prognostically worse than an otherwise complex karyotype

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.88

7 January 2021

Identifiers

DOI

10.1038/LEU.2013.88

1 reference

Dimensions Publication ID

26 July 2017

1038581255

0 references

1 reference